酪酸梭菌活菌散辅助治疗新生儿病理性黄疸的效果

Abstract
Figure/Table
References (20)
Related Citation (10)

Download: PDF (613 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical efficacy of oral administration of Clostridium butyricum powder in the treatment of neonatal pathological jaundice. Methods Eighty term newborns with pathological jaundice born in the Department of Pediatrics of People′s Hospital of Dachang Hui Autonomous County from January 2015 to January 2016 were selected, and they were divide into control group and observation group by randomized digital table, with 40 cases in each group. The newborns in the control group were received routine treatment such as blue light therapy and liver enzyme inducer. In the observation group, the neonates were taken twice daily on the basis of conventional treatment, and 500 mg of Clostridium butyricum powder was taken daily for 5 days. The changes of serum total bilirubin levels before and after treatment were observed in both groups, and the daily bilirubin levels, peak bilirubin concentrations, duration of jaundice, and yellowing of the inner tube within 72 h were compared. Results There was no significant difference in serum total bilirubin levels between the two groups before treatment (P > 0.05). After treatment, the peak serum bilirubin concentration in the observation group was significantly lower than that in the control group, and the incidence of newborns with hyperbilirubinemia was 17.5%, which was lower than that of the control group (40.0%), the difference was statistically significant (P < 0.05). The daily decrease in neonatal serum bilirubin in the observation group was significantly higher than that in the control group, the difference was statistically significant (P < 0.01). After treatment, the duration of jaundice in the observation group was significantly shorter than that of the control group and the rate of yellowing of the inner tuberculosis within 72 h after birth was significantly higher than that of the control group, the difference was statistically significant (P < 0.05). Conclusion Oral administration of Clostridium butyricum powder, as an adjuvant therapy, can effectively reduce the level of bilirubin in the serum of pathological jaundice newborns and shorten the duration of neonatal jaundice, and it is worthy of clinical application.

Key words： Clostridium butyricum powder Live bacteria Pathological jaundice Neonate Bilirubin

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Yan

Cite this article:

LI Yan. Adjuvant therapeutic effect of Clostridium butyricum powder on neonatal pathological jaundice[J]. 中国医药导报, 2018, 15(18): 88-91.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2018/V15/I18/88

[1] Mreihil K，Benth JS，Stensvold HJ，et al. Phototherapy is commonly used for neonatal jaundice but greater control is needed to avoid toxicity in the most vulnerable infants [J]. Acta Paediatr，2017，107（4）：25-28.
[2] Riordan SM，Bittel DC，Le Pichon JB，et al. A Hypothesis for Using Pathway Genetic Load Analysis for Understanding Complex Outcomes in Bilirubin Encephalopathy [J]. Front Neurosci，2016，10（3）：376-379.
[3] 罗嫚丽，曹文芳，刘豫军，等.布拉氏酵母菌联合茵栀黄口服液治疗新生儿黄疸临床观察[J].山东医药，2016，56（8）：79-80.
[4] 张瑛.酪酸梭菌二联活菌散剂辅助治疗新生儿黄疸的临床效果观察[J].中国实用医药，2016，20（11）：8-9.
[5] 张艳红，张超.酪酸梭菌二联活菌散联合茵栀黄口服液治疗新生儿黄疸的临床效果[J].临床医学研究与实践，2017，2（8）：111-112.
[6] 魏克伦，王玉山.关于新生儿病理性黄疸诊断标准的讨论[J].中华儿科杂志，2009，47（1）：17-18.
[7] 江星.蓝光治疗新生儿黄疸的临床效果分析[J].罕少疾病杂志，2016，23（6）：44-45.
[8] Slusher TM，Day LT，Ogundele T，et al. Filtered sunlight，solar powered phototherapy and other strategies for managing neonatal jaundice in low-resource settings [J]. Early Hum Dev，2017，114：11-15.
[9] Chen Z，Zhang L，Zeng L，et al. Probiotics Supplementation Therapy for Pathological Neonatal Jaundice：A Systematic Review and Meta-Analysis [J]. Front Pharmacol，2017，8：432.
[10] 贾承英，崔彦敏，张青，等.不同蓝光照射方法联合妈咪爱治疗新生儿黄疸的效果观察[J].中国妇幼保健，2014， 29（15）：2358-2360.
[11] 刘英，庞淑慧，冯芹.酪酸梭菌活菌散治疗小儿消化不良性腹泻的效果观察[J].中国生化药物杂志，2017，37（5）：90-92.
[12] 夏丽红.酪酸梭菌活菌散治疗儿童腹泻的疗效及机制[J].中国生化药物杂志，2012，33（2）：184-186.
[13] 任玉蓉，徐渲.无乳糖奶粉联合酪酸梭菌活菌散治疗轮状病毒性肠炎的疗效分析[J].实用临床医药杂志，2013， 17（13）：162-165.
[14] 杨晓丽，车彦玲.酪酸梭菌活菌散辅助治疗新生儿高胆红素血症的效果[J].青岛大学医学院学报，2012，48（6）：546-548.
[15] 姚建宏，李小艳，张新华，等.酪酸梭菌活菌散辅助治疗新生儿黄疸的随机多中心临床疗效观察[J].中国微生态学杂志，2016，28（10）：1178-1180.
[16] 张少辉，李宝静，王志华，等.酪酸梭菌活菌散联合醒脾养儿颗粒治疗小儿消化不良性腹泻的效果观察[J].医学综述，2016，22（12）：2425-2427.
[17] 白进，黄彩虹，张斌.小儿腹泻散联合酪酸梭菌活菌散对抗生素相关性腹泻患儿hs-CRP、IL-8、IL-12及TNF-α的影响[J].陕西中医，2017，38（7）：837-838.
[18] 陈峰，李司鹏.酪酸梭菌活菌散对新生儿高胆红素血症治疗效果的影响[J].中国基层医药，2012，19（9）：1372-1373.
[19] 李娅，崔云龙.酪酸梭菌活菌散在治疗母乳性黄疸中的应用[J].中国微生态学杂志，2009，21（5）：447-448.
[20] 孙洁，林方.酪酸梭菌活菌散剂辅助治疗新生儿高胆红素血症的临床效果分析[J].医学综述，2016，22（3）：594-595，599.